Abstract: Devices, systems and methods are disclosed for measurement and reduction or prevention of fluid movement in lactiferous ducts, detection of diseased conditions in the breasts, and treatments thereof. Such techniques, methods and devices are applicable to a variety of conditions including carcinomas.

Abstract: The present disclosure serves to reduce the healing time of tissue wounds, including those formed during surgery, whether necessary or elective (including cosmetic surgery), by providing a therapeutic dose of a pancreatic enzyme inhibitor.

Abstract: Devices, systems and methods are disclosed which relate to training a user in controlling and limiting total calorie consumption, and consequently body weight, by encouraging the user to perform specified consuming actions such as chewing slowly, adjusting a time interval between bites, detecting the early points of satiation, etc. The disclosure is therefore a “calorie pacer” that naturally reduces calorie consumption by re-teaching a user how to eat on a step-by-step basis. The slower eating pace results in a person feeling full before the intake of excessive food portions. The result is fewer calories consumed. Sensors and microcontrollers throughout a place setting are utilized to prompt the user, for example, when to take bites, how big of a bite to take, when to take a drink, etc and record the data in an efficient manner that allows for analysis, monitoring of progress, and personalized feedback.

Abstract: Materials and methods for detecting the early onset of shock and multi-organ failure by production of tissue breakdown products in biological samples (e.g., expired air).

Abstract: Techniques, methods and lavages are disclosed for prevention or treatment of shock, particularly cecal ligation or cecal inoculation shock, by administering a specific therapeutic agent, which is able to use smaller volumes of reagent to achieve partial to complete inhibition, than other previously described techniques. The agent includes a combination of enzyme inhibitor, cytotoxic lipid binding protein, and antibiotic.

Abstract: Techniques are disclosed for prevention or treatment of physiological shock by administering a specific therapeutic agent, which is able to use smaller volumes of reagent to achieve complete inhibition, than other previously described techniques.

Abstract: Techniques are disclosed for prevention or treatment of physiological shock by administering a specific therapeutic agent or combination of therapeutic agents, which is/are able to use smaller volumes of reagent to achieve complete inhibition, than other previously described techniques.

Abstract: Devices, systems and methods are disclosed which relate to training a user in controlling and limiting total calorie consumption, and consequently body weight, by encouraging the user to perform specified consuming actions such as chewing slowly, adjusting a time interval between bites, detecting the early points of satiation, etc. The disclosure is therefore a “calorie pacer” that naturally reduces calorie consumption by re-teaching a user how to eat on a step-by-step basis. The slower eating pace results in a person feeling full before the intake of excessive food portions. The result is fewer calories consumed. Sensors and microcontrollers throughout a place setting are utilized to prompt the user, for example, when to take bites, how big of a bite to take, when to take a drink, etc and record the data in an efficient manner that allows for analysis, monitoring of progress, and personalized feedback.

Abstract: Methods and apparatuses for treating or preventing disorders related to inflammation are provided. In the methods and apparatuses, a glass fiber filter or other filter is used to remove mediators of inflammation from a bodily fluid.